Gilead begins testing inhalable form of remdesivir for COVID-19

Gilead Sciences Inc said on Wednesday it has started an early-stage study of its antiviral COVID-19 treatment remdesivir that can be inhaled, for use outside of hospitals.

from bdnews24.com - Home https://ift.tt/3gIDyae